Aytu Operating Income from 2010 to 2025

AYTU Stock

USD 1.74 0.04 2.25%

Aytu BioScience Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income will likely drop to about -5 M in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Aytu BioScience generates from its operations. View All Fundamentals

Operating Income

First Reported

2006-03-31

Previous Quarter

-3.6 M

Current Value

-930 K

Quarterly Volatility

7.1 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10 M, Interest Expense of 5.2 M or Selling General Administrative of 27.2 M, as well as many indicators such as Price To Sales Ratio of 289, Dividend Yield of 0.0 or PTB Ratio of 3.5. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.

Check out the analysis of Aytu BioScience Correlation against competitors.

For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Latest Aytu BioScience's Operating Income Growth Pattern

Below is the plot of the Operating Income of Aytu BioScience over the last few years. Operating Income is the amount of profit realized from Aytu BioScience operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Aytu BioScience is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Aytu BioScience's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aytu BioScience's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Aytu Operating Income Regression Statistics

	Arithmetic Mean	(9,155,264)
	Coefficient Of Variation	(177.40)
	Mean Deviation	11,316,241
	Median	(6,346,834)
	Standard Deviation	16,241,561
	Sample Variance	263.8T
	Range	75.5M
	R-Value	(0.02)
	Mean Square Error	282.5T
	R-Squared	0.0006
	Significance	0.93
	Slope	(83,111)
	Total Sum of Squares	3956.8T

Aytu Operating Income History

	2025	-5 M
	2024	-4.7 M
	2023	-5.3 M
	2022	-17.1 M
	2021	37.2 M
	2020	-38.2 M
	2019	-20.9 M

Other Fundumenentals of Aytu BioScience

Non Operating Income Net Other

Aytu BioScience Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Current Deferred Revenue	Capital Surpluse	Intangible Assets	Property Plant Equipment	Net Receivables	Good Will	Deferred Long Term Liab	Long Term Debt	Short Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total
Total Assets		0.89	-0.52	-0.75	0.99	0.94	0.98	0.66	-0.44	-0.31	0.83	0.88	0.95	0.89	0.86	0.85	-0.7	0.37	-0.65	0.54	0.96	0.15	0.25	-0.3
Total Stockholder Equity	0.89		-0.74	-0.41	0.83	0.69	0.82	0.74	-0.35	0.06	0.58	0.63	0.81	0.68	0.54	0.53	-0.51	0.13	-0.48	0.64	0.97	0.35	0.52	0.02
Net Debt	-0.52	-0.74		0.1	-0.47	-0.28	-0.5	-0.27	0.29	-0.56	-0.01	-0.41	-0.4	-0.09	-0.08	-0.16	0.39	-0.17	0.35	-0.16	-0.62	-0.86	-0.85	-0.1
Retained Earnings	-0.75	-0.41	0.1		-0.82	-0.91	-0.82	-0.18	0.5	0.65	-0.86	-0.93	-0.84	-0.78	-0.93	-0.95	0.79	-0.73	0.75	-0.02	-0.56	0.05	0.11	0.44
Accounts Payable	0.99	0.83	-0.47	-0.82		0.97	0.99	0.58	-0.47	-0.36	0.85	0.92	0.96	0.88	0.9	0.89	-0.74	0.44	-0.68	0.44	0.92	0.13	0.19	-0.35
Total Liab	0.94	0.69	-0.28	-0.91	0.97		0.97	0.51	-0.46	-0.54	0.91	0.94	0.94	0.92	0.97	0.97	-0.75	0.5	-0.7	0.38	0.82	-0.02	0.01	-0.46
Total Current Assets	0.98	0.82	-0.5	-0.82	0.99	0.97		0.54	-0.45	-0.32	0.83	0.93	0.95	0.85	0.9	0.9	-0.73	0.45	-0.68	0.41	0.91	0.2	0.23	-0.38
Short Term Debt	0.66	0.74	-0.27	-0.18	0.58	0.51	0.54		-0.3	-0.21	0.51	0.32	0.57	0.68	0.42	0.35	-0.21	-0.29	-0.17	0.94	0.72	-0.24	-0.02	0.0
Common Stock	-0.44	-0.35	0.29	0.5	-0.47	-0.46	-0.45	-0.3		0.19	-0.34	-0.6	-0.49	-0.35	-0.38	-0.42	0.63	-0.5	0.59	0.02	-0.33	-0.13	-0.07	0.17
Net Tangible Assets	-0.31	0.06	-0.56	0.65	-0.36	-0.54	-0.32	-0.21	0.19		-0.71	-0.4	-0.43	-0.65	-0.66	-0.62	0.41	-0.34	0.37	-0.16	-0.12	0.72	0.72	0.29
Current Deferred Revenue	0.83	0.58	-0.01	-0.86	0.85	0.91	0.83	0.51	-0.34	-0.71		0.79	0.91	0.96	0.94	0.9	-0.6	0.43	-0.56	0.41	0.71	-0.29	-0.17	-0.25
Capital Surpluse	0.88	0.63	-0.41	-0.93	0.92	0.94	0.93	0.32	-0.6	-0.4	0.79		0.89	0.77	0.88	0.93	-0.86	0.7	-0.82	0.13	0.75	0.21	0.17	-0.49
Intangible Assets	0.95	0.81	-0.4	-0.84	0.96	0.94	0.95	0.57	-0.49	-0.43	0.91	0.89		0.9	0.87	0.88	-0.74	0.5	-0.69	0.41	0.87	0.08	0.19	-0.18
Property Plant Equipment	0.89	0.68	-0.09	-0.78	0.88	0.92	0.85	0.68	-0.35	-0.65	0.96	0.77	0.9		0.91	0.87	-0.61	0.31	-0.57	0.59	0.81	-0.3	-0.13	-0.33
Net Receivables	0.86	0.54	-0.08	-0.93	0.9	0.97	0.9	0.42	-0.38	-0.66	0.94	0.88	0.87	0.91		0.97	-0.66	0.48	-0.62	0.33	0.71	-0.18	-0.18	-0.5
Good Will	0.85	0.53	-0.16	-0.95	0.89	0.97	0.9	0.35	-0.42	-0.62	0.9	0.93	0.88	0.87	0.97		-0.74	0.57	-0.69	0.23	0.69	-0.06	-0.08	-0.53
Deferred Long Term Liab	-0.7	-0.51	0.39	0.79	-0.74	-0.75	-0.73	-0.21	0.63	0.41	-0.6	-0.86	-0.74	-0.61	-0.66	-0.74		-0.83	0.97	0.02	-0.59	-0.25	-0.16	0.29
Long Term Debt	0.37	0.13	-0.17	-0.73	0.44	0.5	0.45	-0.29	-0.5	-0.34	0.43	0.7	0.5	0.31	0.48	0.57	-0.83		-0.86	-0.5	0.21	0.29	0.12	-0.22
Short Term Investments	-0.65	-0.48	0.35	0.75	-0.68	-0.7	-0.68	-0.17	0.59	0.37	-0.56	-0.82	-0.69	-0.57	-0.62	-0.69	0.97	-0.86		0.05	-0.56	-0.25	-0.15	0.28
Short Long Term Debt	0.54	0.64	-0.16	-0.02	0.44	0.38	0.41	0.94	0.02	-0.16	0.41	0.13	0.41	0.59	0.33	0.23	0.02	-0.5	0.05		0.65	-0.32	-0.08	0.01
Net Invested Capital	0.96	0.97	-0.62	-0.56	0.92	0.82	0.91	0.72	-0.33	-0.12	0.71	0.75	0.87	0.81	0.71	0.69	-0.59	0.21	-0.56	0.65		0.23	0.39	-0.17
Net Working Capital	0.15	0.35	-0.86	0.05	0.13	-0.02	0.2	-0.24	-0.13	0.72	-0.29	0.21	0.08	-0.3	-0.18	-0.06	-0.25	0.29	-0.25	-0.32	0.23		0.89	0.11
Capital Stock	0.25	0.52	-0.85	0.11	0.19	0.01	0.23	-0.02	-0.07	0.72	-0.17	0.17	0.19	-0.13	-0.18	-0.08	-0.16	0.12	-0.15	-0.08	0.39	0.89		0.24
Long Term Debt Total	-0.3	0.02	-0.1	0.44	-0.35	-0.46	-0.38	0.0	0.17	0.29	-0.25	-0.49	-0.18	-0.33	-0.5	-0.53	0.29	-0.22	0.28	0.01	-0.17	0.11	0.24

Click cells to compare fundamentals

About Aytu BioScience Financial Statements

Aytu BioScience shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-4.7 M	-5 M
Non Operating Income Net Other	11.6 M	12.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aytu Operating Income from 2010 to 2025

Latest Aytu BioScience's Operating Income Growth Pattern

Aytu Operating Income Regression Statistics

Aytu Operating Income History

Other Fundumenentals of Aytu BioScience

Aytu BioScience Operating Income component correlations

About Aytu BioScience Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Aytu Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY